menu
    • menu

    Company profile for Orion Corporation

    Fermion-PSE
    News
    Abilita and Orion Announce Research Collab to Next-Gen Antibody

    19 Dec 2024

    // PRESS RELEASE

    Orion Board Member Penalized for Delayed Transaction Notification

    12 Dec 2024

    // GLOBENEWSWIRE

    Orion Corporation Enters Collaboration with Evariste on Inhibitors

    10 Dec 2024

    // BUSINESSWIRE

    DATA COMPILATION
    #PharmaFlow

    Fermion

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's customers are mainly healthcare service providers and professionals such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centres, clinics, etc.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orion CorporationFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Head officeOrion CorporationOrionintie 1A, FI-02200 Espoo, FinlandP.O.Box 65, ...
    Telephone
    Telephone
    +358 10 4261
    Client Email
    Email
    fermionSales@fermion.fi
    Client Website
    Website
    https://www.orion.fi/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orion-corporation/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Abilita and Orion Announce Research Collab to Next-Gen Antibody
    Abilita and Orion Announce Research Collab to Next-Gen Antibody

    19 Dec 2024

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-abilita-therapeutics-announce-research-collaboration-and-option-to-license-agreement-to-develop-innovative-antibody-therapeutics/

    PRESS RELEASE
    19 Dec 2024
    Share Share
    Orion Board Member Penalized for Delayed Transaction Notification
    Orion Board Member Penalized for Delayed Transaction Notification

    12 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/12/2996458/0/en/Penalty-payment-to-a-member-of-Orion-s-Board-of-Directors-for-delay-in-notifying-managers-transaction.html

    GLOBENEWSWIRE
    12 Dec 2024
    Share Share
    Orion Corporation Enters Collaboration with Evariste on Inhibitors
    Orion Corporation Enters Collaboration with Evariste on Inhibitors

    10 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210955238/en

    BUSINESSWIRE
    10 Dec 2024
    Share Share
    142,701 Orion Corporation A shares converted into B shares
    142,701 Orion Corporation A shares converted into B shares

    27 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/27/2987966/0/en/142-701-Orion-Corporation-A-shares-converted-into-B-shares.html

    GLOBENEWSWIRE
    27 Nov 2024
    Share Share
    Orion Research Foundation grants EUR 1,109,000 for research in 2025
    Orion Research Foundation grants EUR 1,109,000 for research in 2025

    22 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/11/22/2985732/0/en/Orion-Research-Foundation-grants-EUR-1-109-000-for-research-in-2025.html

    GLOBENEWSWIRE
    22 Nov 2024
    Share Share
    Orion and Alligator Bio amend agreement 2 bispecific antibodies
    Orion and Alligator Bio amend agreement 2 bispecific antibodies

    20 Nov 2024

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-alligator-bioscience-amend-their-agreement-concerning-two-bispecific-antibodies/

    PRESS RELEASE
    20 Nov 2024
    Share Share

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search